Clinical Variables Associated with Survival and Treatment Response in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

被引:0
|
作者
Haring, C. T. [1 ]
Kana, L. [2 ]
Dermody, S. [1 ]
Smith, J. D. [1 ]
Brenner, J. C. [1 ]
Casper, K. [1 ]
Chinn, S. B. [1 ]
Malloy, K. [1 ]
Mierzwa, M. L. [3 ]
Prince, M. E. [1 ]
Rosko, A. J. [1 ]
Schonewolf, C. [3 ]
Shah, J. L. [3 ]
Stucken, C. L. [1 ]
Shuman, A. [1 ]
Spector, M. [4 ]
Worden, F. [4 ]
Swiecicki, P. L. [5 ]
机构
[1] Univ Michigan, Dept Otolaryngol, Ann Arbor, MI 48109 USA
[2] Wayne State Univ, Dept Otolaryngol, Detroit, MI 48201 USA
[3] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Dept Internal Med, Div Med Oncol, Ann Arbor, MI 48109 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
172
引用
收藏
页码:E44 / E44
页数:1
相关论文
共 50 条
  • [1] Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Greenhalgh, J.
    Bagust, A.
    Boland, A.
    Fleeman, N.
    McLeod, C.
    Dundar, Y.
    Proudlove, C.
    Shaw, R.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 49 - 54
  • [2] Optimizing Treatment for Head and Neck Cancers: Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
    Haddad, Robert, I
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (07): : 982 - 984
  • [3] Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Sacco, Assuntina G.
    Cohen, Ezra E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29) : 3305 - +
  • [4] Ifosfamide and mitoxantrone in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Thurnher, D
    Kornfehl, J
    Burian, M
    Gedlicka, C
    Selzer, E
    Quint, C
    Neuchrist, C
    Kornek, GV
    [J]. ANTI-CANCER DRUGS, 2001, 12 (03) : 205 - 208
  • [5] Immunotherapy Breakthroughs in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Borel, Christian
    Jung, Alain C.
    Burgy, Mickael
    [J]. CANCERS, 2020, 12 (09) : 1 - 19
  • [6] Topoisomerases in the treatment of metastatic or recurrent squamous carcinoma of the head and neck
    Murphy, BA
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (01) : 85 - 92
  • [7] Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    Hsieh, Ronan W.
    Borson, Steven
    Tsagianni, Anastasia
    Zandberg, Dan P.
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] Immunotherapy in recurrent and or metastatic squamous cell carcinoma of the head and neck
    Saada-Bouzid, Esma
    Peyrade, Frederic
    Guigay, Joel
    [J]. CURRENT OPINION IN ONCOLOGY, 2019, 31 (03) : 146 - 151
  • [9] Chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck
    Fanucchi, M
    Khuri, FR
    [J]. SEMINARS IN ONCOLOGY, 2004, 31 (06) : 809 - 815
  • [10] Drug Insight: cetuximab in the treatment of recurrent and metastatic squamous cell carcinoma of the head and neck
    Bernier, Jacques
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (12): : 705 - 713